clorazepate dipotassium

Preferred Label : clorazepate dipotassium;

MeSH definition : A water-soluble benzodiazepine derivative effective in the treatment of anxiety. It has also muscle relaxant and anticonvulsant actions.;

MeSH synonym : dipotassium chlorazepate;

CISMeF synonym : chlorazepate, dipotassium; dipotassium, clorazepate;

MeSH Hyperonym : Chlorazepate; Clorazepate;

MeSH hyponym : tranxene; tranxilium; 4306-CB;

Related MeSH term : clorazepate monopotassium;

MeSH CAS label : 1H-1,4-Benzodiazepine-3-carboxylic acid, 7-chloro-2,3-dihydro-2-oxo-5-phenyl-, monopotassium salt, compd. with potassium hydroxide (K(OH)) (1:1);

MeSH Related Number : 57109-90-7 (Clorazepate dipotassium); clorazepate monopotassium; MS63G8NQUI; D51WO0G0L4;

Registry Number MeSH : 57109-90-7;

Related CAS MeSH : MS63G8NQUI (Clorazepate monopotassium);

Wikipedia link : https://en.wikipedia.org/wiki/Clorazepate dipotassium;

Codes EINECS : 260-565-6;

Is substance : O;

UNII : 63FN7G03XY;

InChIKey : QCHSEDTUUKDTIG-UHFFFAOYSA-L;

Details

Origin ID

D003009;

UMLS CUI

C0009033;

ATC code(s)
- potassium clorazepate [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
CISMeF manual mappings
- Dipotassium clorazepate (substance) [SNOMED CT concept]
- Potassium clorazepate adverse reaction (disorder) [SNOMED CT concept]
- Potassium clorazepate poisoning (disorder) [SNOMED CT concept]
- dipotassium clorazepate [Substance BNPC]
Pharmacological action(s)
- GABA modulators [MeSH Descriptor]
- anti-anxiety agents [MeSH Descriptor]
- anticonvulsants [MeSH Descriptor]
- central nervous system depressants [MeSH Descriptor]
- psychotropic drugs [MeSH Descriptor]
Record concept(s)
- 4306-CB [MeSH concept]
- Chlorazepate [MeSH concept]
- Clorazepic Acid [MeSH concept]
- clorazepate dipotassium [MeSH concept]
- clorazepate monopotassium [MeSH concept]
- tranxene [MeSH concept]
- tranxilium [MeSH concept]
Related MeSH Supplementary Concept(s)
- Noctran [MeSH Supplementary Concept]
See also inter- (CISMeF)
- Clorazepate dipotassium (product) [Inactive SNOMED CT concept]
- Tranxene [ICD-11 Extension code]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Clorazepate Dipotassium [NCIt concept]
- Clorazepate dipotassium (product) [Inactive SNOMED CT concept]
- Dipotassium clorazepate [ICD-11 Extension code]
- Dipotassium clorazepate (substance) [SNOMED CT concept]
- clorazepate dipotassium [SNOMED Notion]
- dipotassium clorazepate [Substance BNPC]
- potassium clorazepate [ATC Code]
Validated automatic mappings to NTBT
- Chlorazepate [SMS substance]
- Clorazepate [LOINC component]
- Clorazepate (substance) [SNOMED CT concept]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients